Neuro Dex announced it raised $60,000 in an initial filing from an offering of $750,000

Company

Location

About

NeuroDex develops blood based diagnostics for neurodegenerative disorders. Additionally, we assist and advance neurological research and development by making our one-of-a-kind platform available for collaborations. NeuroDex's technology is based on a unique ability to isolate exosomes derived from neurons (neuronal derived exosomes, or NDE's) and analyzing these.